- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Sharps Technology Inc: Sharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary | 78 | GlobeNewswire (Europe) | NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our... ► Artikel lesen | |
| 30.01. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 29.01. | Sharps Technology Inc: Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering | 2 | GlobeNewswire (USA) | ||
| 28.01. | Sharps Technology tumbles on pricing underwritten public offering | 6 | Seeking Alpha | ||
| SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 28.01. | Sharps Technology sets $20 million public offering price | 3 | Investing.com | ||
| 28.01. | Sharps Technology Inc: Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering | 1 | GlobeNewswire (USA) | ||
| 22.01. | Sharps Technology Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 10.01. | Sharps Technology Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 23.12.24 | Sharps Technology files to sell 37,013 shares of common stock for holders | 6 | Seeking Alpha | ||
| 23.12.24 | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.12.24 | Sharps Technology Inc: Sharps Technology's CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue | 154 | GlobeNewswire (Europe) | Shareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing expansion, and expected delivery scheduleInitial... ► Artikel lesen | |
| 05.12.24 | Sharps Technology Inc: Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard | 4 | GlobeNewswire (USA) | ||
| 05.12.24 | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.11.24 | Sharps Technology Inc: Sharps Regains Nasdaq Listing Compliance | 155 | GlobeNewswire (Europe) | NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 14.11.24 | Sharps Technology Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.11.24 | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.10.24 | Sharps Technology to effect 1-for-22 reverse stock split | 2 | Seeking Alpha | ||
| 14.10.24 | Sharps Technology Inc: Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date | 120 | GlobeNewswire (Europe) | NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 10.10.24 | Aktionäre von Sharps Technology stimmen Aktienzusammenlegung zu | 1 | Investing.com Deutsch | ||
| 10.10.24 | Sharps Technology shareholders approve reverse stock split | 1 | Investing.com |
Seite:
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRATEC | 26,550 | -2,21 % | EQS-PVR: STRATEC SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: STRATEC SE
STRATEC SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
10.03.2025 / 16:16 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,117 | -2,83 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D | LONDON, Ontario and BOSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it's... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,693 | +1,46 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications | SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,986 | +2,26 % | Ping An Healthcare and Technology Company Limited: Ping An Health Pioneers AI-Driven Healthcare with DeepSeek Integration | HONG KONG and SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) recently... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,014 | -23,60 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,462 | -7,60 % | Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance | The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/... ► Artikel lesen | |
| CYTOSORBENTS | 0,972 | +3,62 % | Cytosorbents Corp - 8-K, Current Report | ||
| VERU | 0,475 | +2,99 % | Veru Aktie: Glänzende Aussichten steigern Hoffnung! | Der Biopharmahersteller Veru befindet sich aktuell in einer positiven Entwicklungsphase. Anfang März 2025 zeigt die Aktie deutliche Anzeichen einer Erholung vom 52-Wochen-Tief von 0,49 US-Dollar. Mit... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,716 | -1,78 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
| VOLITIONRX | 0,625 | 0,00 % | VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, November 15 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Nov. 14, 2024... ► Artikel lesen | |
| EKSO BIONICS | 0,314 | -3,09 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results | SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 0,820 | -1,80 % | Imunon, Inc.: IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study | IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in... ► Artikel lesen | |
| BEYOND AIR | 0,238 | +1,71 % | Beyond Air Expands LungFit PH With Distribution Deals In 4 Countries; Stock Up In Pre-market | ||
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,591 | +0,51 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights |
SHARPS TECHNOLOGY INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -16,87 % bei einem Aktienkurs von 0,345 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHARPS TECHNOLOGY INC finden Sie auf Wallstreet Online.
